Aurinia Pharmaceuticals Inc. (AUPH) Return on equity 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
49.4%FY2025 · since FY2018: -39.1% → 49.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 49.4% | +47.9 pp |
| FY2024 | 1.5% | +22.2 pp |
| FY2023 | -20.6% | +6.0 pp |
| FY2022 | -26.7% | +11.1 pp |
| FY2021 | -37.8% | -12.6 pp |
| FY2020 | -25.2% | +4.4 pp |
| FY2019 | -29.6% | +9.5 pp |
| FY2018 | -39.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice